AMRUTANJANPharmaceuticals
Amrutanjan Health Care Ltd — Profit & Loss Statement
₹493.65
-1.89%
Amrutanjan Health Care Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -0.06 Cr | -0.56 Cr | — |
| Tax Rate For Calcs | 0.26 | 0.27 | 0.26 | 0.26 | — |
| Normalized EBITDA | 75.88 Cr | 68.16 Cr | 59.18 Cr | 97.03 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 50.83 Cr | 44.97 Cr | 39.83 Cr | 67.19 Cr | — |
| Reconciled Depreciation | 6.53 Cr | 6.06 Cr | 5.21 Cr | 3.80 Cr | — |
| Reconciled Cost Of Revenue | 223.21 Cr | 211.83 Cr | 181.98 Cr | 180.46 Cr | — |
| EBITDA | 75.88 Cr | 68.16 Cr | 58.93 Cr | 94.86 Cr | — |
| EBIT | 69.35 Cr | 62.10 Cr | 53.72 Cr | 91.06 Cr | — |
| Net Interest Income | -0.22 Cr | -0.16 Cr | 11.56 Cr | 10.59 Cr | — |
| Interest Expense | 0.22 Cr | 0.16 Cr | 0.08 Cr | 0.48 Cr | — |
| Normalized Income | 50.83 Cr | 44.97 Cr | 40.01 Cr | 68.80 Cr | — |
| Net Income From Continuing And Discontinued Operation | 50.83 Cr | 44.97 Cr | 39.83 Cr | 67.19 Cr | — |
| Total Expenses | 400.14 Cr | 375.48 Cr | 336.16 Cr | 322.57 Cr | — |
| Diluted Average Shares | 2.89 Cr | 2.90 Cr | 2.92 Cr | 2.92 Cr | — |
| Basic Average Shares | 2.89 Cr | 2.90 Cr | 2.92 Cr | 2.92 Cr | — |
| Diluted EPS | 17.58 | 15.50 | 13.63 | 22.98 | — |
| Basic EPS | 17.58 | 15.50 | 13.65 | 23.00 | — |
| Diluted NI Availto Com Stockholders | 50.83 Cr | 44.97 Cr | 39.83 Cr | 67.19 Cr | — |
| Net Income Common Stockholders | 50.83 Cr | 44.97 Cr | 39.83 Cr | 67.19 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 50.83 Cr | 44.97 Cr | 39.83 Cr | 67.19 Cr | — |
| Net Income Including Noncontrolling Interests | 50.83 Cr | 44.97 Cr | 39.83 Cr | 67.19 Cr | — |
| Net Income Continuous Operations | 50.83 Cr | 44.97 Cr | 39.83 Cr | 67.19 Cr | — |
| Tax Provision | 18.30 Cr | 16.97 Cr | 13.81 Cr | 23.39 Cr | — |
| Pretax Income | 69.13 Cr | 61.95 Cr | 53.65 Cr | 90.58 Cr | — |
| Other Non Operating Income Expenses | 17.68 Cr | 16.35 Cr | 0.02 Cr | 0.07 Cr | — |
| Net Non Operating Interest Income Expense | -0.22 Cr | -0.16 Cr | 11.56 Cr | 10.59 Cr | — |
| Interest Expense Non Operating | 0.22 Cr | 0.16 Cr | 0.08 Cr | 0.48 Cr | — |
| Operating Income | 51.67 Cr | 45.75 Cr | 42.06 Cr | 81.97 Cr | — |
| Operating Expense | 176.93 Cr | 163.65 Cr | 154.18 Cr | 142.11 Cr | — |
| Other Operating Expenses | 55.20 Cr | 57.48 Cr | 18.58 Cr | 9.66 Cr | — |
| Depreciation And Amortization In Income Statement | 6.53 Cr | 6.06 Cr | 5.21 Cr | 3.80 Cr | — |
| Depreciation Income Statement | 6.53 Cr | 6.06 Cr | 4.42 Cr | 3.66 Cr | — |
| Selling General And Administration | 56.11 Cr | 52.42 Cr | 77.17 Cr | 75.66 Cr | — |
| Selling And Marketing Expense | 56.11 Cr | 52.42 Cr | 72.71 Cr | 72.94 Cr | — |
| Gross Profit | 228.61 Cr | 209.40 Cr | 196.25 Cr | 224.08 Cr | — |
| Cost Of Revenue | 223.21 Cr | 211.83 Cr | 181.98 Cr | 180.46 Cr | — |
| Total Revenue | 451.82 Cr | 421.23 Cr | 378.23 Cr | 404.55 Cr | — |
| Operating Revenue | 451.82 Cr | 421.23 Cr | 378.23 Cr | 404.55 Cr | — |
| Total Unusual Items | — | -0.76 Cr | -0.24 Cr | -2.18 Cr | -7.89 Cr |
| Total Unusual Items Excluding Goodwill | — | -0.76 Cr | -0.24 Cr | -2.18 Cr | -7.89 Cr |
| Interest Income | — | 14.80 Cr | 11.78 Cr | 11.17 Cr | 9.39 Cr |
| Rent Expense Supplemental | — | 0.71 Cr | 0.41 Cr | 0.25 Cr | 0.35 Cr |
| Special Income Charges | — | -0.63 Cr | -0.04 Cr | -2.04 Cr | -7.53 Cr |
| Other Special Charges | — | -0.16 Cr | -0.03 Cr | — | -0.09 Cr |
| Write Off | — | 0.68 Cr | 0.06 Cr | 2.04 Cr | 7.62 Cr |
| Impairment Of Capital Assets | — | 0.11 Cr | 0.00 | — | — |
| Total Other Finance Cost | — | 0.09 Cr | 0.15 Cr | 0.10 Cr | 0.09 Cr |
| Interest Income Non Operating | — | 14.80 Cr | 11.78 Cr | 11.17 Cr | 9.39 Cr |
| Amortization | — | 0.85 Cr | 0.79 Cr | 0.14 Cr | 0.17 Cr |
| General And Administrative Expense | — | 5.20 Cr | 4.46 Cr | 2.73 Cr | 2.44 Cr |
| Rent And Landing Fees | — | 0.71 Cr | 0.41 Cr | 0.25 Cr | 0.35 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Amrutanjan Health Care Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.